# AlphaFold2 vs. Rosetta: Which Protein Structure Prediction Platform Should You Use for Your Research?

## Direct Answer and Scope

For a computational biologist facing a protein structure prediction task, the choice between AlphaFold2 and Rosetta depends on three factors: the biological question, the available compute, and the need for interpretable biophysical sampling. AlphaFold2 delivers high-accuracy single-chain and complex predictions from sequence alone with minimal user intervention, while Rosetta provides a flexible energy-based modeling environment for docking, design, and conformational sampling that AlphaFold2 does not directly support. This article compares both platforms across methodology, input requirements, output quality, scalability, and user community, then provides practical recommendations based on protein type and available resources. The guidance applies to biology students, researchers, laboratory professionals, and life-science practitioners who need to select a prediction platform for a specific task instead of mastering either tool exhaustively.

## Platform Origins and Design Philosophy

### AlphaFold2 as a Deep Learning End-to-End Predictor

AlphaFold2 emerged from the DeepMind group and represents a fundamental shift in protein structure prediction. The system takes an amino acid sequence and multiple sequence alignment (MSA) as input, then uses an attention-based neural network architecture to directly predict atomic coordinates. The model learns from the evolutionary record encoded in sequence alignments, identifying co-evolutionary signals that constrain three-dimensional structure. For a researcher, this means the platform performs best when a protein has many homologous sequences available in public databases, because the MSA provides the evolutionary information the network needs to infer spatial contacts.

The practical consequence is that AlphaFold2 operates as a single-pass predictor. You submit a sequence, the model runs inference, and you receive a predicted structure with per-residue confidence scores. There is no explicit energy function being minimized during prediction, and the user does not specify physical restraints or force field parameters. This design makes AlphaFold2 accessible to researchers who do not have deep expertise in molecular mechanics.

### Rosetta as a Physics-Based Modeling Suite

Rosetta is not a single program but a collection of software applications developed over decades by the Rosetta Commons community. The platform uses a physically motivated energy function that approximates the free energy of a protein conformation. Structure prediction in Rosetta proceeds through fragment assembly and Monte Carlo sampling, where the algorithm explores conformational space and evaluates each candidate against the energy function. The lowest-energy conformations are assumed to be closest to the native state.

For a researcher, Rosetta requires more explicit decision-making than AlphaFold2. You must choose a scoring function, define constraints, select a sampling protocol, and often provide starting structures or fragments. The platform excels at tasks that require conformational sampling, such as protein-protein docking, loop modeling, and sequence design. Rosetta also supports symmetric assemblies and can model large multimeric complexes through specialized applications like SymDock.

## Input Requirements and Data Preparation

### Sequence and Alignment Needs for AlphaFold2

AlphaFold2 requires an amino acid sequence and a multiple sequence alignment. The standard pipeline generates the MSA using jackhmmer searches against sequence databases such as UniRef and metagenomic collections. The quality of the MSA directly affects prediction accuracy. Proteins with deep evolutionary families produce rich alignments that allow the network to identify strong co-evolutionary signals. Orphan proteins with few homologs often yield lower-confidence predictions.

The [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/) provide access to sequence databases and search tools that researchers can use to assess sequence availability before running AlphaFold2. Checking the number of homologs in public databases is a practical first step in deciding whether AlphaFold2 will perform well for a given target. If the sequence has few detectable homologs, the predicted structure may still be useful but should be interpreted with caution.

### Structure and Fragment Requirements for Rosetta

Rosetta prediction protocols typically require more input preparation than AlphaFold2. Ab initio structure prediction in Rosetta uses short sequence fragments derived from known protein structures. These fragments are generated by scanning the target sequence against a database of solved structures and identifying segments with similar local sequence properties. The fragment library provides the building blocks for conformational sampling.

For comparative modeling or refinement tasks, Rosetta requires a starting template structure. The user must identify a suitable template through fold recognition or homology search, then align the target sequence to the template. This workflow demands more bioinformatics skill than AlphaFold2, because the user must evaluate template quality and decide how to handle insertions and deletions.

### Practical Data Preparation Workflow

A practical workflow for either platform begins with sequence validation. Confirm that the sequence corresponds to the intended protein and that no truncations or mutations have been introduced during cloning or synthesis. The [EMBL-EBI Training](https://www.ebi.ac.uk/training) materials provide structured learning pathways for sequence analysis and database searching that can help researchers build the skills needed for this preparation step.

For AlphaFold2, the next step is generating the MSA and checking its depth. For Rosetta, the next step is deciding whether the task requires ab initio prediction, comparative modeling, docking, or design, because each task uses a different protocol with different input files.

## Methodology Comparison

### Neural Network Architecture versus Energy Function

AlphaFold2 uses a transformer-based architecture that processes the MSA and sequence through multiple layers of attention. The network learns to map evolutionary information to spatial coordinates through training on experimentally determined structures. The model produces a predicted distance distribution and torsion angle distribution for each residue pair, then uses these predictions to assemble a three-dimensional structure through a structure module that operates in three-dimensional space.

Rosetta uses a knowledge-based energy function that approximates the physical forces governing protein stability. The energy function includes terms for van der Waals interactions, hydrogen bonding, solvation, electrostatics, and backbone torsion preferences. During sampling, Rosetta evaluates candidate conformations against this energy function and accepts or rejects moves based on Monte Carlo criteria. The energy function has been refined over many years through benchmarking against experimentally determined structures.

### Confidence Estimation and Model Quality

AlphaFold2 provides per-residue confidence scores called pLDDT (predicted local distance difference test) and a predicted aligned error (PAE) matrix. The pLDDT score ranges from 0 to 100 and indicates the model's confidence in the local structure around each residue. The PAE matrix provides pairwise estimates of positional error between residues, which helps identify domains that may be correctly folded individually but incorrectly oriented relative to each other.

Rosetta does not provide a built-in confidence score in the same way. Instead, the platform produces an energy score for each model, and the user typically generates multiple models and clusters them to identify the most populated conformational basin. The Rosetta energy score is not directly comparable to pLDDT, and interpreting it requires understanding the energy function and the sampling protocol used.

### Handling of Conformational Change

A critical difference between the platforms is their handling of conformational change. AlphaFold2 predicts a single static structure for a given sequence and MSA. The model does not sample alternative conformations, and it may predict an averaged or functionally irrelevant state for proteins that undergo large conformational changes upon binding or activation.

Rosetta explicitly samples conformational space and can capture alternative states. The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) demonstrated that combining Rosetta docking approaches with deep learning methods improved predictions for flexible complexes. For a GP2 bacteriophage protein target, the Rosetta-based docking routine improved the DockQ score from 0.62 for AlphaFold2-multimer to 0.77, effectively capturing binding-induced conformational changes. This result illustrates that when conformational flexibility is central to the biological question, Rosetta's sampling capability provides an advantage over AlphaFold2's single-shot prediction.

## Output Quality and Interpretation

### Coordinate Files and Confidence Metrics

Both platforms output protein structure files in standard formats that can be visualized and analyzed in molecular graphics software. AlphaFold2 produces PDB-format files with B-factor columns repurposed to store pLDDT confidence values. Rosetta produces PDB files with energy terms stored in the remark records or in separate score files.

For AlphaFold2 output, the researcher should examine the pLDDT plot to identify low-confidence regions. Regions with pLDDT below 50 are likely disordered or poorly predicted and should not be overinterpreted. The PAE matrix helps identify domain orientations that may be unreliable. For Rosetta output, the researcher should examine the energy distribution across the generated models and consider the cluster population, beyond the lowest-energy model.

### Model Selection Criteria

AlphaFold2 model selection is straightforward because the platform ranks its five output models by confidence. The researcher typically uses the model with the highest overall confidence or examines all five models to assess prediction stability. If the five models agree closely, the prediction is likely reliable. If they diverge, the prediction should be treated with caution.

Rosetta model selection requires more judgment. The researcher generates hundreds or thousands of models, then clusters them based on structural similarity. The largest cluster often contains the most reliable prediction, even if its energy is slightly higher than an outlier model. The researcher should also check whether the models satisfy known biochemical constraints, such as disulfide bond patterns or ligand binding site requirements.

### Comparison with Experimental Data

The most rigorous validation for either platform is comparison with experimental data. If the researcher has access to experimental structures for related proteins, comparing the predicted structure with the experimental template provides a direct accuracy assessment. The [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/) maintain structure databases and search tools that can help identify experimentally determined structures for comparison.

For proteins without experimental structures, the researcher can use indirect validation. Cross-linking mass spectrometry data, hydrogen-deuterium exchange data, or mutagenesis results can provide constraints that the predicted structure should satisfy. The [Support Field Neural Representation Learner framework study](https://doi.org/10.1038/s44385-025-00045-7) demonstrates that residue-level stability values correlate with biophysical markers such as RMSF and B-factors, suggesting that stability-aware analysis can complement structure prediction.

## At a Glance

| Feature | AlphaFold2 | Rosetta |
|---------|-----------|---------|
| Core method | Deep learning neural network trained on experimental structures | Physics-based energy function with Monte Carlo sampling |
| Primary input | Amino acid sequence and multiple sequence alignment | Sequence, fragments, template structures, or docking partners |
| Typical compute | GPU recommended, single inference pass per model | CPU or cluster, hundreds to thousands of models generated |
| Confidence output | Per-residue pLDDT and PAE matrix | Energy scores requiring clustering and expert interpretation |
| Conformational sampling | Limited to single static prediction | Explicit sampling of alternative conformations |
| Best suited for | High-throughput prediction of well-conserved proteins | Docking, design, flexible complexes, and conformational analysis |
| User skill required | Moderate, minimal parameter tuning | Advanced, protocol selection and parameter optimization needed |
| Reproducibility | High, deterministic given same MSA and model weights | Moderate, stochastic sampling requires seed control |

## Computational Cost and Scalability

### Hardware Requirements for AlphaFold2

AlphaFold2 requires a GPU for practical use. The neural network inference step is computationally intensive, and running on CPU is impractically slow for most applications. The MSA generation step is also computationally demanding because it involves searching large sequence databases. A typical AlphaFold2 run for a single protein of moderate size takes minutes to hours on a modern GPU, depending on sequence length and MSA depth.

For high-throughput applications, AlphaFold2 can be run in batch mode, processing many sequences sequentially or in parallel across multiple GPUs. The platform's deterministic nature means that the same input produces the same output, which simplifies reproducibility. Researchers running large-scale proteome-wide predictions should plan for substantial storage requirements, because each prediction produces multiple output files.

### Rosetta Compute Demands

Rosetta is more flexible in its hardware requirements but generally more compute-intensive per prediction task. Ab initio structure prediction requires generating thousands of models to achieve convergence, and each model requires many Monte Carlo sampling steps. This workflow is typically run on a computing cluster with many CPU cores. GPU acceleration is available for some Rosetta applications but is not universally implemented.

Docking protocols vary in cost depending on the size of the complex and the sampling thoroughness. The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) demonstrated that RosettaDock 4.0 and ReplicaDock 2.0 were used to enhance backbone conformational sampling for flexible complexes, indicating that these protocols require substantial compute resources. For large symmetric complexes, SymDock 2.0 successfully predicted a human DNA repair protein complex with A10 stoichiometry, but such predictions require careful resource planning.

### Cost-Benefit Decision Framework

The computational cost difference between the platforms should inform the platform choice. For a researcher with limited compute access, AlphaFold2 offers a lower barrier to entry because a single GPU can produce a high-quality prediction for a well-conserved protein. Rosetta's sampling requirements may be prohibitive for researchers without cluster access.

However, the cost comparison changes when the biological question requires conformational sampling. If the researcher needs to predict how two proteins interact, explore alternative binding modes, or design mutations that stabilize a particular conformation, Rosetta's sampling capability justifies its higher compute cost. The decision should be based on the information content of the output, beyond the wall-clock time of the run.

## Practical Workflow for Platform Selection

### Step 1: Define the Biological Question

The first step in platform selection is articulating the specific prediction task. The researcher should ask whether the goal is to obtain a static structure for a single protein, predict a protein-protein complex, explore conformational alternatives, or design new sequences. Each task maps to a different platform strength.

For a single protein with a deep MSA, AlphaFold2 is the appropriate starting point. For a protein-protein complex with known binding partners, AlphaFold2-multimer can generate a complex prediction, but Rosetta docking may be needed to refine the interface or capture conformational changes. For design tasks, Rosetta is the only option among the two platforms because AlphaFold2 does not perform sequence design.

### Step 2: Assess Sequence Availability

Before committing to a platform, the researcher should assess the availability of homologous sequences. The [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/) provide search tools that can quantify the number of homologs for a given protein. A deep MSA with hundreds or thousands of effective sequences suggests that AlphaFold2 will perform well. A shallow MSA with fewer than 30 effective sequences suggests that the prediction may be lower confidence, and Rosetta's energy-based approach may provide complementary information.

The researcher should also consider whether the protein has known structural homologs. If a template structure exists, Rosetta comparative modeling may be more appropriate than ab initio prediction. The template provides a starting point that reduces the conformational search space.

### Step 3: Evaluate Compute Resources

The researcher should inventory available compute resources before selecting a platform. A single GPU workstation can support AlphaFold2 predictions for most proteins. Rosetta ab initio prediction and extensive docking studies require cluster access or cloud computing resources. The [nf-core Documentation](https://nf-co.re/docs) provides standards for reproducible pipeline configuration that can help researchers plan compute-intensive workflows.

For researchers with limited compute, a practical strategy is to run AlphaFold2 first to obtain a baseline prediction, then use Rosetta only for specific refinement tasks. This hybrid approach leverages AlphaFold2's accuracy for the global fold while using Rosetta's sampling for local refinement or conformational exploration.

### Step 4: Run Initial Predictions and Assess Quality

After selecting a platform, the researcher should run initial predictions and assess output quality before committing to a full production run. For AlphaFold2, this means examining the pLDDT plot and PAE matrix for the first prediction. For Rosetta, this means generating a small set of models and checking the energy distribution and cluster structure.

The [Galaxy Training Network](https://training.galaxyproject.org/) provides accessible workflow training that can help researchers build the skills needed to run and interpret structure prediction tools. The [Carpentries Lessons](https://carpentries.org/lessons) provide foundational computing skills, including shell and Git, that are useful for managing prediction workflows and tracking analysis versions.

### Step 5: Validate Against Known Constraints

The researcher should validate predictions against any known biochemical or biophysical constraints. If the protein is known to bind a specific ligand, the predicted structure should have a plausible binding site. If disulfide bonds are known to form between specific cysteine residues, the predicted structure should place those residues in proximity.

The [Support Field Neural Representation Learner framework study](https://doi.org/10.1038/s44385-025-00045-7) provides an approach for assessing structural stability that can complement prediction quality assessment. By computing residue-level support values that correlate with RMSF and B-factors, the researcher can identify regions of the predicted structure that are likely to be stable versus flexible.

## Records and Measurements for Reproducibility

### Documenting Prediction Parameters

Reproducibility requires careful documentation of all prediction parameters. For AlphaFold2, the researcher should record the database version used for MSA generation, the model version, and any custom settings. For Rosetta, the researcher should record the score function, the protocol flags, the random seed, and the number of models generated.

The [Bioconductor](https://bioconductor.org/) project provides documentation on reproducible genomic-analysis workflows that can inform structure prediction documentation practices. While Bioconductor focuses on genomic analysis, its principles of version control, dependency management, and workflow documentation apply equally to structure prediction.

### Storing Inputs and Outputs

The researcher should store all input files, including sequences, MSAs, and template structures, in a versioned directory structure. Output files should be organized by prediction run, with clear naming conventions that include the target protein, the platform, and the date. The [nf-core Documentation](https://nf-co.re/docs) provides standards for pipeline output organization that can be adapted for structure prediction workflows.

For AlphaFold2, the researcher should store the MSA files because they are required for reproducing the prediction. For Rosetta, the researcher should store the fragment libraries and any starting structures because these inputs affect the sampling trajectory.

### Tracking Model Versions

Both platforms undergo periodic updates that change prediction behavior. The researcher should record the exact software version used for each prediction run. This information is essential for comparing predictions across time and for troubleshooting unexpected results.

The [EMBL-EBI Training](https://www.ebi.ac.uk/training) materials provide guidance on data management practices that support reproducibility. Researchers should adopt these practices even for small-scale prediction projects, because the cost of documentation is low compared with the cost of reproducing an undocumented analysis.

## Common Failure Patterns and Troubleshooting

### Low-Confidence AlphaFold2 Predictions

A common failure pattern for AlphaFold2 is low pLDDT scores across large regions of the protein. This pattern typically indicates that the MSA is shallow or that the protein contains intrinsically disordered regions. The researcher should first check the MSA depth and consider whether additional sequence search iterations would improve the alignment.

If the low-confidence regions correspond to known disordered regions, the prediction may still be useful for the ordered domains. The researcher should not discard the entire prediction but should focus analysis on the high-confidence regions. The PAE matrix can help identify whether the low-confidence regions are truly disordered or whether they represent domains with uncertain relative orientation.

### Rosetta Sampling Convergence Failure

A common failure pattern for Rosetta is failure to converge, where the generated models do not cluster into a dominant structural basin. This pattern indicates that the sampling protocol is not exploring conformational space effectively or that the energy function does not strongly favor a single conformation.

The researcher should increase the number of models, adjust the sampling temperature, or modify the fragment library. For docking protocols, the researcher should check whether the starting structures are appropriate and whether the search space is too large. The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) demonstrated that flexible complexes remain challenging for both Rosetta and deep learning approaches, so convergence failure for these targets should be expected and documented.

### Mismatch Between Predicted and Experimental Data

When predicted structures conflict with experimental data, the researcher should first verify that the experimental data were interpreted correctly. If the conflict persists, the researcher should consider whether the protein adopts multiple conformations and whether the prediction captured one conformation while the experiment captured another.

The researcher should also consider whether post-translational modifications, ligand binding, or oligomerization affect the structure. AlphaFold2 predicts the structure of the isolated sequence, and Rosetta predictions depend on the input constraints. Neither platform automatically accounts for modifications or binding partners unless the researcher explicitly includes them.

## Limitations and Interpretation Boundaries

### AlphaFold2 Limitations

AlphaFold2 has several documented limitations that the researcher should acknowledge. The platform predicts a single static structure and does not capture conformational ensembles. For proteins that undergo large conformational changes upon binding, the predicted structure may not represent the biologically relevant state.

AlphaFold2 also has limited accuracy for certain protein classes. Membrane proteins, proteins with unusual cofactors, and proteins with extensive post-translational modifications may be predicted with lower accuracy. The platform's performance depends on the training data distribution, and proteins that are underrepresented in the training set may be predicted less accurately.

The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) noted that although predictors have achieved modest improvements in accuracy for simpler targets post-AlphaFold2, performance for more flexible complexes remains limited. This finding underscores that AlphaFold2 is not a universal solution for all structure prediction tasks.

### Rosetta Limitations

Rosetta's limitations stem from its energy function approximation and sampling stochasticity. The energy function is a knowledge-based approximation that may not accurately capture the energetics of unusual protein environments. The sampling protocols are stochastic, meaning that different runs may produce different results unless the random seed is controlled.

Rosetta also requires substantial expertise to use effectively. The platform offers many protocols and parameters, and selecting the appropriate combination for a given task requires experience. Novice users may produce poor predictions because they selected inappropriate parameters.

### Domain of Applicability

The researcher should define the domain of applicability for each prediction. A prediction is valid only within the range of protein types and tasks for which the platform has been benchmarked. The researcher should not extrapolate prediction quality from one protein class to another without supporting evidence.

The [recurrent evolution of ligand-binding domain multiplicity study](https://doi.org/10.1038/s41467-026-73340-5) demonstrates that protein structures can diverge in unexpected ways across lineages. A prediction platform trained on known structures may not accurately predict novel domain architectures that have no precedent in the training data. The researcher should treat predictions for unusual proteins with appropriate skepticism.

## Welfare and Safety Context

### Responsible Use of Prediction Results

Structure prediction results should be used responsibly, particularly when they inform experimental design or biomedical research. The researcher should not treat predicted structures as experimental determinations. Predictions require experimental validation before they are used to guide decisions about drug design, protein engineering, or clinical applications.

The researcher should also consider the broader implications of prediction accuracy. Overconfident interpretation of inaccurate predictions can lead to wasted experimental effort or, in biomedical contexts, to unsafe conclusions. The researcher should communicate prediction confidence clearly in reports and publications.

### Data Management and Security

Structure prediction workflows involve handling sequence data that may be subject to data protection regulations. The researcher should ensure that sequence data are stored and processed in compliance with applicable regulations. The [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/) provide guidance on data submission and access policies that can inform data management practices.

For collaborative projects, the researcher should establish clear data sharing agreements before running predictions. The [nf-core Documentation](https://nf-co.re/docs) provides standards for collaborative pipeline development that can support responsible data sharing.

### Professional Escalation Criteria

The researcher should escalate to a supervisor or collaborator when prediction results will inform high-stakes decisions. Specific escalation criteria include:

- Predictions that will guide experimental design for a funded project should be reviewed by the principal investigator before experiments are initiated.
- Predictions that will be included in a publication should be reviewed by all co-authors, with particular attention to confidence metrics and limitations.
- Predictions that will inform clinical or therapeutic decisions should be reviewed by domain experts and validated experimentally before any action is taken.
- Predictions that conflict with established experimental data should be discussed with the experimentalists who generated the data before the conflict is resolved.

## Decision Matrix for Protein Type and Task Complexity

Beyond the general platform comparison, a practical decision matrix helps match specific protein types and research tasks to the appropriate platform or hybrid workflow. This framework translates the methodological differences into concrete choices a computational biologist can apply before committing compute resources.

### Single-Domain Globular Proteins with Deep Evolutionary Families

For a monomeric globular protein with hundreds or thousands of detectable homologs, AlphaFold2 is the default choice. The deep multiple sequence alignment provides the evolutionary signal the network needs to produce high-confidence predictions. A researcher should run AlphaFold2 first and examine the pLDDT distribution. If the median pLDDT exceeds 90 and the PAE matrix shows consistent domain orientations across all five output models, the prediction is likely suitable for downstream analysis without Rosetta refinement.

The compute cost for this scenario is modest. A single GPU can process a 300-residue protein in under an hour including MSA generation. The [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/) provide the sequence databases and search tools needed to assess MSA depth before committing to a full prediction run. Checking the effective number of sequences in the alignment is a five-minute step that prevents wasted compute on targets unlikely to produce reliable predictions.

### Multi-Domain Proteins with Uncertain Domain Arrangements

Multi-domain proteins present a distinct challenge because AlphaFold2 may predict individual domains accurately while misorienting them relative to each other. The PAE matrix is the primary diagnostic tool for this failure mode. When the PAE matrix shows high predicted aligned error between domains, the relative orientation is unreliable even if individual domains have high pLDDT.

For this protein class, a hybrid workflow is appropriate. Run AlphaFold2 to obtain the domain structures, then use Rosetta to sample alternative domain arrangements. The Rosetta docking protocol can treat each domain as a rigid body and explore the relative orientations that satisfy the energy function. The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) demonstrated that combining Rosetta docking with deep learning predictions improved accuracy for complexes with conformational flexibility, and the same principle applies to multi-domain proteins with uncertain interdomain arrangements.

The researcher should generate at least 1000 Rosetta models for domain arrangement sampling and cluster the output to identify the dominant conformational basin. If the largest cluster contains models that satisfy known biochemical constraints, such as an active site cleft formed by two domains, the prediction gains credibility.

### Flexible Complexes and Binding-Induced Conformational Changes

Protein-protein complexes that undergo large conformational changes upon binding represent the most challenging scenario for both platforms. AlphaFold2-multimer predicts a single static complex structure and may miss the biologically relevant bound conformation. The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) showed that for a GP2 bacteriophage protein target, Rosetta-based docking improved the DockQ score from 0.62 for AlphaFold2-multimer to 0.77 by capturing binding-induced conformational changes.

For this protein class, Rosetta is the primary platform, with AlphaFold2 serving as a starting point. The workflow begins with AlphaFold2-multimer to generate an initial complex model, then uses RosettaDock or ReplicaDock to sample backbone and side-chain conformations at the interface. The researcher should expect to run thousands of docking models and should plan for cluster compute. The [nf-core Documentation](https://nf-co.re/docs) provides standards for configuring reproducible high-throughput workflows that can manage the compute demands of extensive docking studies.

The researcher should document the conformational change captured in the Rosetta models by measuring the interface RMSD between the AlphaFold2 starting model and the final Rosetta models. A large interface RMSD indicates that the docking protocol sampled meaningful conformational change, while a small RMSD suggests the complex is relatively rigid.

### Large Symmetric Assemblies

Symmetric protein complexes require specialized treatment because neither platform handles symmetry automatically. AlphaFold2-multimer can predict asymmetric complexes but may struggle with large symmetric assemblies due to memory constraints and the difficulty of capturing symmetry in the attention mechanism. Rosetta provides SymDock for symmetric docking, which explicitly enforces symmetry during sampling.

The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) demonstrated successful prediction of a human DNA repair protein complex with A10 stoichiometry using Rosetta-based SymDock 2.0. For large symmetric complexes, the researcher should use Rosetta SymDock with the appropriate symmetry definition file. The symmetry definition specifies the rotational and translational symmetry operators that relate the subunits.

The compute cost for symmetric docking is substantial but manageable because symmetry reduces the effective search space. The researcher should generate at least 500 models and evaluate the energy distribution and cluster population. The [EMBL-EBI Training](https://www.ebi.ac.uk/training) materials provide learning pathways for understanding symmetry in biological assemblies, which helps researchers define the correct symmetry operators for their target complex.

### Antibody and Nanobody Antigen Interactions

Antibody-antigen complexes present specific challenges because the complementarity determining regions are highly variable and the binding interface often involves flexible loops. The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) noted that antibody and nanobody antigen interactions remain challenging for prediction methods.

For this protein class, the researcher should use a specialized workflow. AlphaFold2 can predict the antibody structure with high confidence because antibody frameworks are well represented in the training data. The complementarity determining region loops, however, may have lower confidence because of their sequence variability. Rosetta loop modeling can refine these regions, and RosettaDock can sample the antibody-antigen interface.

The researcher should generate multiple AlphaFold2 models and select the one with the highest confidence in the complementarity determining regions. Rosetta loop remodeling should then be applied to the complementarity determining region loops, followed by docking to the antigen. The [Support Field Neural Representation Learner framework study](https://doi.org/10.1038/s44385-025-00045-7) provides an approach for assessing residue-level stability that can help identify which complementarity determining region residues are likely to be flexible and require careful sampling.

### Peptides and Short Sequences

For peptides shorter than 50 amino acids, the prediction landscape differs from globular proteins. The [Enhanced Methodology for Peptide Tertiary Structure Prediction study](https://doi.org/10.3390/ijms26157484) demonstrated that bio-inspired algorithms combined with energy minimization can achieve competitive results for peptides up to 50 amino acids and surpass leading protein folding algorithms for peptides up to 30 amino acids.

AlphaFold2 may produce lower-confidence predictions for short peptides because the MSA is often shallow and the peptide may not adopt a stable tertiary structure in isolation. Rosetta ab initio prediction with fragment assembly can sample the conformational space more thoroughly for short sequences. The researcher should consider whether the peptide adopts a defined structure in context or only upon binding to a partner.

For peptide-protein interactions, the researcher should model the peptide in the context of the binding partner. AlphaFold2-multimer can predict the complex, but the peptide conformation may be more reliable if Rosetta docking is used to refine the interface. The researcher should generate multiple models and compare the peptide conformations to assess prediction stability.

### Membrane Proteins

Membrane proteins present unique challenges because both platforms have limited training data for this protein class. AlphaFold2 can predict membrane protein structures with moderate confidence, but the lipid environment is not explicitly modeled. Rosetta has membrane-specific energy functions and sampling protocols that account for the hydrophobic core and hydrophilic headgroup regions of the lipid bilayer.

For membrane proteins, the researcher should use AlphaFold2 as a starting point and Rosetta membrane refinement to optimize the structure in the membrane context. The Rosetta membrane energy function includes terms for membrane insertion depth and orientation that are not present in soluble protein energy functions. The researcher should specify the membrane spanning regions and the membrane thickness when running Rosetta membrane refinement.

The [recurrent evolution of ligand-binding domain multiplicity study](https://doi.org/10.1038/s41467-026-73340-5) demonstrates that receptor architectures can diverge across lineages in unexpected ways. Membrane receptors with novel domain arrangements may not be well represented in the training data for either platform, and predictions should be treated with caution.

## Record System for Platform Selection Decisions

A structured record system helps the researcher document platform selection decisions and their rationale. This record becomes valuable when revisiting a prediction task, comparing results across projects, or troubleshooting unexpected outcomes.

### Prediction Task Log

For each prediction task, the researcher should record the protein identifier, the biological question, the selected platform or hybrid workflow, and the rationale for the selection. The rationale should reference the decision matrix criteria, including MSA depth, expected conformational flexibility, complex stoichiometry, and available compute resources.

The [Bioconductor](https://bioconductor.org/) project provides documentation on reproducible analysis workflows that can inform the structure of a prediction task log. While Bioconductor focuses on genomic analysis, its principles of structured documentation and version control apply equally to structure prediction.

### Parameter and Version Registry

The researcher should maintain a registry of software versions and parameters for each prediction run. For AlphaFold2, this includes the database version used for MSA generation, the model parameters, and any custom settings. For Rosetta, this includes the score function, the protocol flags, the random seed, and the number of models generated.

The [nf-core Documentation](https://nf-co.re/docs) provides standards for pipeline configuration and version tracking that can be adapted for structure prediction workflows. The researcher should record the exact command line used for each run, including all flags and input file paths.

### Outcome Assessment Record

After completing a prediction run, the researcher should record the outcome assessment. For AlphaFold2, this includes the median pLDDT, the PAE matrix interpretation, and the agreement among the five output models. For Rosetta, this includes the energy distribution, the cluster population, and the structural agreement among the top models.

The outcome assessment should also include any validation against experimental data or known biochemical constraints. The [Support Field Neural Representation Learner framework study](https://doi.org/10.1038/s44385-025-00045-7) provides an approach for computing residue-level stability values that correlate with biophysical markers, which can serve as an additional validation layer for predicted structures.

## Troubleshooting Method for Platform Selection Errors

### Misdiagnosing the Biological Question

A common error is selecting a platform based on the protein type without fully considering the biological question. For example, a researcher may choose AlphaFold2 for a single-chain prediction when the actual question requires understanding conformational change upon ligand binding. The researcher should revisit the biological question and ask whether a static structure is sufficient or whether conformational sampling is required.

The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) demonstrated that flexible complexes remain challenging for both platforms, and the researcher should not expect either platform to fully resolve conformational questions without careful protocol design. If the biological question involves conformational change, the researcher should plan for a Rosetta sampling workflow from the outset instead of attempting to extract conformational information from AlphaFold2 output.

### Overlooking MSA Depth Limitations

A second common error is running AlphaFold2 without first assessing MSA depth. The researcher may spend significant compute producing a low-confidence prediction that could have been anticipated by checking the number of homologous sequences. The [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/) provide search tools that quantify sequence availability, and this check should be a mandatory first step.

If the MSA is shallow, the researcher should consider whether additional sequence search iterations or alternative databases would improve the alignment. If the MSA remains shallow, the researcher should switch to Rosetta or use a hybrid approach where AlphaFold2 provides a starting model and Rosetta refinement explores alternative conformations.

### Underestimating Rosetta Compute Requirements

A third common error is underestimating the compute requirements for Rosetta production runs. The researcher may plan for a small number of models and find that the sampling has not converged. The [Galaxy Training Network](https://training.galaxyproject.org/) provides accessible workflow training that can help researchers estimate compute requirements before launching production runs.

The researcher should run a small test set of 50 to 100 models first and examine the energy distribution and cluster structure. If the models have not converged, the researcher should increase the model count or adjust the sampling parameters before committing to a full production run. The [Carpentries Lessons](https://carpentries.org/lessons) provide foundational computing skills that help researchers manage large-scale compute workflows efficiently.

### Ignoring Confidence Metrics

A fourth common error is ignoring the confidence metrics provided by each platform. The researcher may use a low-confidence AlphaFold2 prediction without examining the pLDDT plot or may select a Rosetta model based solely on energy without examining the cluster population. The researcher should always examine the confidence metrics before using a prediction for downstream analysis.

For AlphaFold2, the researcher should examine the pLDDT plot and PAE matrix for every prediction. For Rosetta, the researcher should examine the energy distribution and cluster structure for every production run. The [EMBL-EBI Training](https://www.ebi.ac.uk/training) materials provide guidance on interpreting structure prediction confidence metrics and incorporating them into analysis workflows.

## Professional Escalation Criteria for Platform Selection

The researcher should escalate platform selection decisions to a supervisor or collaborator under specific circumstances. These criteria ensure that high-stakes decisions receive appropriate review.

### Novel Protein Classes

If the target protein belongs to a class that is underrepresented in the training data for either platform, the researcher should escalate the platform selection decision. Examples include proteins with unusual cofactors, extensive post-translational modifications, or novel domain architectures. The [recurrent evolution of ligand-binding domain multiplicity study](https://doi.org/10.1038/s41467-026-73340-5) demonstrates that protein structures can diverge in unexpected ways across lineages, and predictions for such proteins require careful interpretation.

### High-Stakes Applications

If the prediction will inform drug design, clinical decisions, or other high-stakes applications, the researcher should escalate the platform selection and prediction interpretation to domain experts. The prediction should be validated experimentally before any action is taken. The researcher should document the prediction confidence and limitations clearly in any report or publication.

### Conflicting Evidence

If the prediction conflicts with established experimental data, the researcher should escalate the conflict to the experimentalists who generated the data. The conflict may indicate that the prediction is inaccurate, that the experimental data were misinterpreted, or that the protein adopts multiple conformations. The researcher should not resolve the conflict without consulting the relevant experts.

### Resource-Intensive Workflows

If the selected workflow requires substantial compute resources, the researcher should escalate the resource allocation decision to the appropriate institutional authority. The [nf-core Documentation](https://nf-co.re/docs) provides standards for reproducible pipeline configuration that can help researchers justify resource requests and document compute usage.

## Frequently Asked Questions

### Can AlphaFold2 replace Rosetta for all protein structure prediction tasks?

No. AlphaFold2 excels at predicting static structures for proteins with deep evolutionary families, but it does not perform conformational sampling, protein design, or docking refinement. Rosetta remains necessary for tasks that require exploring alternative conformations, designing new sequences, or modeling flexible complexes. The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) demonstrated that Rosetta docking approaches improved predictions for flexible complexes compared with AlphaFold2-multimer alone, particularly for targets with binding-induced conformational changes.

### How do I decide which platform to use for a protein-protein docking problem?

Start with AlphaFold2-multimer to generate a complex prediction, then assess the confidence of the interface prediction. If the interface has high confidence and the complex is rigid, the AlphaFold2 prediction may be sufficient. If the interface has low confidence or the complex is known to undergo conformational changes, use Rosetta docking to sample alternative binding modes. The [CAPRI rounds 47 through 55 study](https://pubmed.ncbi.nlm.nih.gov/40980933) showed that combining Rosetta docking with deep learning approaches improved accuracy for flexible complexes, suggesting that a hybrid approach is often the most effective strategy.

### What compute resources do I need to run AlphaFold2?

AlphaFold2 requires a GPU for practical use. A modern GPU with at least 16 GB of memory can handle most single-chain predictions. The MSA generation step also requires substantial compute and storage. For high-throughput predictions, multiple GPUs and significant storage capacity are needed. Researchers without GPU access should consider cloud computing options or institutional high-performance computing resources.

### What compute resources do I need to run Rosetta?

Rosetta can run on CPU-only systems, but ab initio prediction and extensive docking studies require substantial compute. A typical ab initio prediction generates thousands of models, which can take days on a single CPU core. Researchers should plan to use a computing cluster or cloud resources for production Rosetta runs. The [nf-core Documentation](https://nf-co.re/docs) provides guidance on configuring reproducible workflows that can help researchers manage Rosetta compute requirements.

### How do I assess the quality of an AlphaFold2 prediction?

Examine the per-residue pLDDT scores and the predicted aligned error matrix. High pLDDT scores above 90 indicate high confidence, scores between 70 and 90 indicate moderate confidence, and scores below 50 indicate low confidence. The PAE matrix helps identify whether domains are correctly oriented relative to each other. Compare the five output models to assess prediction stability. If the models agree closely, the prediction is likely reliable.

### How do I assess the quality of a Rosetta prediction?

Generate multiple models and cluster them based on structural similarity. The largest cluster typically contains the most reliable prediction. Examine the energy distribution across models and check whether the lowest-energy models are structurally similar. Validate the prediction against known biochemical constraints, such as disulfide bond patterns or ligand binding sites. The [Support Field Neural Representation Learner framework study](https://doi.org/10.1038/s44385-025-00045-7) provides an additional approach for assessing structural stability that can complement Rosetta energy analysis.

### What should I do if my protein has very few homologous sequences?

AlphaFold2 may produce lower-confidence predictions for proteins with shallow MSAs. Consider whether the protein has structural homologs that could serve as templates for Rosetta comparative modeling. The [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/) provide tools for searching structure databases that can help identify potential templates. If no templates exist, Rosetta ab initio prediction may be the only option, but the prediction should be treated with caution and validated experimentally.

### How should I report structure prediction results in a publication?

Report the platform version, input data, prediction parameters, and confidence metrics. For AlphaFold2, report the pLDDT scores and PAE matrix. For Rosetta, report the score function, sampling protocol, and model selection criteria. Describe the limitations of the prediction and any validation performed. The [EMBL-EBI Training](https://www.ebi.ac.uk/training) materials provide guidance on data management and reporting practices that support reproducible research.

## Related Bioinformatics Guides

- [How To Use Alphafold To Predict Structure: Structural Analysis and Computational Methodologies in Bioinformatics](/knowledge/bioinformatics/how-to-use-alphafold-to-predict-structure)
- [Structural Prediction of Bat Coronavirus Spike Proteins: Insights from AlphaFold2 and Molecular Dynamics](/knowledge/bioinformatics/structural-prediction-bat-coronavirus-spike-proteins-alphafold2-molecular-dynamics)
- [Deep Learning-Driven Protein Structure Prediction for Emerging Zoonotic Viruses: From AlphaFold2 to Next-Generation Therapeutics](/knowledge/bioinformatics/deep-learning-protein-structure-prediction-zoonotic-viruses)
- [Digital Pathology Scanners: A Buyer's Guide for Clinical and Research Use](/knowledge/bioinformatics/digital-pathology-scanners-a-buyer-s-guide-for-clinical-and-research-use)
- [Persistent Identifiers for Research Data: A Guide to Selection and Use](/knowledge/bioinformatics/persistent-identifiers-for-research-data-a-guide-to-selection-and-use)

## References and Further Reading

- [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/). National Center for Biotechnology Information.
- [EMBL-EBI Training](https://www.ebi.ac.uk/training). European Bioinformatics Institute.
- [Bioconductor](https://bioconductor.org/). Bioconductor Project.
- [Galaxy Training Network](https://training.galaxyproject.org/). Galaxy Project.
- [nf-core Documentation](https://nf-co.re/docs). nf-core.
- [The Carpentries Lessons](https://carpentries.org/lessons). The Carpentries.
- [Docking With Rosetta and Deep Learning Approaches in CAPRI Rounds 47-55.](https://pubmed.ncbi.nlm.nih.gov/40980933). Proteins, 2025.
- [Recurrent evolution of ligand-binding domain multiplicity fine-tunes TGFβ signaling in vertebrates.](https://doi.org/10.1038/s41467-026-73340-5). 2026.
- [Support field neural representation learner framework for learning stability landscapes in molecular geometry.](https://doi.org/10.1038/s44385-025-00045-7). 2025.
- [Enhanced Methodology for Peptide Tertiary Structure Prediction Using GRSA and Bio-Inspired Algorithm.](https://doi.org/10.3390/ijms26157484). 2025.
- [163TiP Phase II/III trial of first-line pumitamig (PD-L1 × VEGF-A bsAb) + chemotherapy vs bevacizumab + chemotherapy in unresectable/metastatic colorectal cancer (ROSETTA CRC-203)](https://doi.org/10.1016/j.annonc.2026.05.162). Annals of Oncology, 2026.

> This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.